{"id":"W2571353014","doi":"10.1016/j.ccell.2016.12.002","title":"Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Genomics Institute; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; St. Baldrick's Foundation; Ministero dell’Istruzione, dell’Università e della Ricerca; AbbVie; Janssen Biotech; Innovative Medicines Initiative; Associazione Italiana per la Ricerca sul Cancro; Wellcome; Merck; Takeda Pharmaceuticals U.S.A.; Pfizer; Boehringer Ingelheim","keywords":"Epigenetics; Druggability; Chromatin; Biology; Small interfering RNA; Cancer research; Methyltransferase; Genetics; Bioinformatics; Cell biology; RNA; Gene; Methylation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006555881,0.0001371415,0.0001814223,0.00005667427,0.0001356061,0.00007303761,0.00006427509,0.00007463228,0.0000580898],"category_scores_gemma":[0.0000475117,0.0001227122,0.00004483711,0.00004404252,0.00008796104,0.0001651848,0.00003955647,0.0001606031,0.00001292008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001165634,"about_ca_system_score_gemma":0.0001122975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001004795,"about_ca_topic_score_gemma":0.000294882,"domain_scores_codex":[0.9990484,0.00003207077,0.0001478192,0.0003222447,0.0001726435,0.0002767967],"domain_scores_gemma":[0.9993374,0.00006277487,0.0001145481,0.0002763425,0.00006381225,0.0001450705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001497463,0.0003440628,0.01595361,0.0002316776,0.00006478998,0.00007027842,0.0001046569,0.00001813633,0.934723,0.00005916168,0.0001630718,0.04677005],"study_design_scores_gemma":[0.005705947,0.0008954231,0.283749,0.0001242522,0.00007282841,0.000008800718,0.00003798693,0.0003319049,0.7076131,0.001240018,0.000104178,0.0001165643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980068,0.0001877946,0.00009097357,0.0004159664,0.00004941993,0.0007348938,0.00002992867,0.00001916387,0.0004650928],"genre_scores_gemma":[0.9986827,0.0004394829,0.0000561563,0.0001428294,0.0001037411,0.0001600632,0.00002525172,0.00002834584,0.000361392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2677954,"threshold_uncertainty_score":0.5004058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03744754336170057,"score_gpt":0.3529582167922486,"score_spread":0.3155106734305481,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}